Bio-Techne (TECH) Operating Expenses (2009 - 2026)

Bio-Techne's Operating Expenses history runs 18 years deep, the most recent figure standing at $132.8 million for Q1 2026.

• In Q1 2026, Operating Expenses fell 24.48% year-over-year to $132.8 million; the TTM figure through Mar 2026 stood at $632.7 million (up 1.58% YoY), while the FY2025 annual figure was $688.0 million, up 22.2% from the prior year.
• Operating Expenses was $132.8 million for Q1 2026 at Bio-Techne, down from $136.8 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $222.7 million in Q2 2025 to a low of $110.2 million in Q2 2023.
• Historically, Operating Expenses has averaged $139.0 million across 5 years, with a median of $136.8 million in 2025.
• The sharpest annual moves came in 2024 and 2026: Operating Expenses jumped 42.98% in 2024, then declined 24.48% in 2026.
• A 5-year view of Operating Expenses shows it stood at $115.5 million in 2022, then advanced by 20.02% to $138.6 million in 2023, then grew by 5.69% to $146.5 million in 2024, then dropped by 6.59% to $136.8 million in 2025, then retreated by 2.94% to $132.8 million in 2026.
• The last three Operating Expenses figures came in at $132.8 million (Q1 2026), $136.8 million (Q4 2025), and $140.5 million (Q3 2025), per Business Quant data.